5 MBBS medicos of Nalgonda Medical College suspended for ragging juniors

Hyderabad: Taking strict action against ragging complaints from juniors, the authorities of the Nalgonda Government Medical College recently suspended 5 medicos for allegedly abusing, assaulting and harassing their juniors on the campus.

The action was taken based on the recommendation of the anti-ragging committee after confirming the allegations of the freshers who complained to the college management about being ragged verbally and physically by the seniors.

Also read- Forced to stand, dance for 3 hours! GMERS MBBS student dies after ragging, 15 seniors booked

Among the students who have been suspended, two are from the 2020 batch who are facing a 6-month suspension, one student for one month, a first-year student for three months and an intern from the 2019 batch suspended for six months, reports The Hindu. 

In their complaints, the junior students hailing from Kerala alleged that the accused seniors used foul language and assaulted them for not following their orders for the past few days. 

The incident happened in the boy’s hostel on November 11 where five students from Kerala were “ragged physically” by seniors, after which the juniors lodged a complaint with college authorities. 

After receiving the complaints, a preliminary enquiry was conducted by the Anti-Ragging Committee, headed by Principal Dr. N. Srivani and comprising faculty members, law enforcement representatives, and specialists. In a meeting, the committee presented evidence of the accused involvement in the ragging and confirmed the allegations of the juniors. Accordingly, the college management suspended the five students for a period ranging from one to six months, 

Speaking to TOI, Dr Naresh from the Junior Doctors’ Association said, “The ragging led to a fight between juniors and seniors. The seniors asked students to dance. They gave them some punishment. They became furious as juniors were disrespectful, and this led to a fight.”

GMC principal N Srivani told the daily, “The decision to suspend seniors was taken based on panel’s recommendation. We got a complaint from first-years that they were ragged in hostel by seniors. We called in anti-ragging committee. They conducted a review and, based on recommendations, we suspended students based on severity of ragging.”

All appropriate measures have been taken to prevent the recurrence of such incidents. Anti-ragging awareness meetings are proposed in association with the Police Department for the students, the college principal told PTI. 

Also read- 10 MBBS students of Mahabubnagar Medical College suspended for ragging juniors

Powered by WPeMatico

NMC extends deadline for PG medical courses annual declaration, to impose fine after 22 November

Through a recent notice, the National Medical Commission (NMC) has announced a further extension of the Last Date for Submission of the Annual Declaration Report for PG Medical Courses.

Medical Colleges or institutes running PG medical courses have been directed by the Apex Medical Commission to submit the said report along with a fee of Rs 50,000 plus 18% GST for each PG medical course on the designated NMC portal by 22.11.2024.

For more information, click on the link below:

Powered by WPeMatico

Consumer court orders hospital, doctors to pay compensation for anaesthesia error

The District Consumer Disputes Redressal Commission (DCDRC), Amritsar recently directed the super-speciality hospital based in 2 cities and 3 treating doctors to refund Rs 7.5 lakh to a woman, whose husband went into a coma while undergoing knee replacement surgery and later died.

It was observed by the Commission that the treating facilities and its doctors did not take proper precautions due to which the patient went into a coma and the complainant had to seek treatment for her husband from a Neuro Hospital by spending around Rs 7,50,000.

For more information, click on the link below:

Powered by WPeMatico

Risk for mortality up with low income in type 2 diabetes

Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years, according to a study published online Nov. 12 in JAMA Network Open.

Powered by WPeMatico

Bloated after that holiday meal? what’s normal, what’s not

As the holidays approach, most folks are familiar with a common side effect of the overindulgence that can come with all those meals with family and friends: Bloating.

Powered by WPeMatico

Is it heartburn or a heart condition? an expert explains

You’ve loaded up on goodies while at a family gathering, and you suddenly feel chest pains. Is it heartburn or something worse?

Powered by WPeMatico

New therapeutic vaccine gives hope against an aggressive breast cancer

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.

Powered by WPeMatico

Exploring how stressful life events affect internalizing and externalizing symptoms of psychopathology in childhood

Past psychology studies have consistently highlighted the link between adverse and traumatic life events and mental health problems. Better understanding the intricate relationship between stressful life events and the emergence of psychopathology in childhood could inform psychotherapeutic practice, potentially enabling the development of more effective interventions.

Powered by WPeMatico

Specific Plasma Biomarkers may Differentiate Hypertrophic Cardiomyopathy from other cardiomyopathies: Study

A novel study conducted by researchers
from New York and Boston identified certain circulating biomarkers that can
distinguish hypertrophic cardiomyopathy (HCM) from other cardiomyopathies. The
study results were published in the journal Circulation: Heart Failure.

Hypertrophic cardiomyopathy (HCM)
is the most common genetic cardiomyopathy with high prevalence. It is often
misdiagnosed and challenging to diagnose due to a lack of specific biomarkers. Research
shows that proteomics profiling can determine the concentration of plasma
proteins. However, there is ambiguity on the specificity of the biomarkers for
various cardiomyopathies, researchers conducted a multicenter case-control
study to identify a small panel of circulating biomarkers to distinguish HCM
from other cardiomyopathies that manifest left ventricular hypertrophy (LVH)
using comprehensive plasma proteomics profiling while adjusting for clinical
confounders.

Also Read: Transcatheter tricuspid valve replacement effective in patients with severe tricuspid regurgitation: Study

The study included adults who
were ≥18 years old from Massachusetts General Hospital and Columbia University
Irving Medical Center and diagnosed with Hypertrophic Cardiomyopathy (HCM) and
controls with hypertensive LVH, transthyretin amyloid cardiomyopathy (ATTR-CM),
or aortic stenosis (AS). The participants were divided into two groups of training
set and a test set. Two-thirds of patients were enrolled in the training
set and one-third in the test set. Protein concentrations in HCM were compared
with those in hypertensive LVH (comparison 1), ATTR-CM (comparison 2), and AS
(comparison 3).

Two criteria were used to select
the candidate proteins. They are consistent abundance of the proteins that will
show higher or lower levels in HCM patients compared to three other
cardiomyopathy groups which should be statistically significant. The proteins
must be significantly associated with HCM even after adjusting for clinical
factors. Three separate analyses were done to compare proteins in HCM patients
to controls. Mann-Whitney-Wilcoxon test with a fold change threshold was done
to identify Proteins with significantly higher or lower abundance in HCM. Clinical
confounders were adjusted using Multivariable logistic regression analysis. the
area under the receiver-operating-characteristic curve (AUC) was used to identify
proteins in the training and the test set.

Findings:

  • Overall, 4,979 proteins in 1,415 patients (HCM,
    n=879; hypertensive LVH, n=331; ATTR-CM, n=169; AS, n=36) were analyzed.
  • Of those, 5 proteins were selected as candidate
    proteins.
  • The logistic regression model with these 5
    proteins had an area under the receiver-operating-characteristic curve of 0.86
    (95% CI 0.82–0.89) in the test set.
  • The MAPK and HIF-1 pathways were dysregulated in
    HCM throughout the 3 comparisons.
Also Read: Sacubitril-Valsartan Improves Cardiac Function Despite Kidney Decline in HFrEF Patients, study reveals

Thus, the study specified 5
proteins that had consistently different abundance in HCM throughout the 3
comparisons. This study is one of its kind to identify the largest and the most
comprehensive proteomic research that elucidates plasma biomarkers that are
independently associated with HCM and other cardiomyopathies. Further research
should be carried out to identify plasma biomarkers that are unique to HCM.

Further research: Comprehensive
Proteomics Profiling Identifies Circulating Biomarkers to Distinguish
Hypertrophic Cardiomyopathy from Other Cardiomyopathies with Left Ventricular
Hypertrophy. Doi: https://doi.org/10.1161/CIRCHEARTFAILURE.124.012434.

Powered by WPeMatico

GLP-1 Agonists: Game Changer in Treating Obesity and Boosting Fertility, Review Reveals

USA: A recent narrative review published in Fertility and Sterility highlights the importance of comprehensive care for patients with obesity and infertility, emphasizing the transformative potential of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs). These medications, initially developed to treat diabetes, are now making waves for their ability to promote significant weight loss comparable to surgical interventions. This advancement marks a pivotal moment in recognizing obesity as a disease, fostering a shift in how healthcare providers approach this condition, particularly in reproductive health.

Obesity is widely recognized as a major factor compromising reproductive outcomes. Individuals with higher body mass index (BMI) often experience reduced fertility and complications in conception and pregnancy. Traditional advice to “eat less and exercise more” has proven inadequate in combating the obesity epidemic. The emergence of GLP-1 RAs provides a promising alternative, addressing neuroendocrine hormone imbalances and offering meaningful, sustained weight loss.

The review, by Alyse S. Goldberg, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada, and Christina E. Boots, Northwestern University, Chicago, Illinois, highlights several crucial aspects of integrating GLP-1 RAs into fertility care. First, understanding their mechanism of action, potential side effects, and implications for pregnancy and anesthesia is vital. For many patients, weight loss before pregnancy can restore ovulation and enhance maternal and fetal outcomes. However, the medications must be carefully managed, including discontinuation before conception or procedures requiring anesthesia.

Reproductive endocrinology and infertility specialists are encouraged to adopt a multidisciplinary approach to obesity management. This includes providing evidence-based, unbiased care with resources like nutritional counseling and mental health support. Collaborating with other specialists ensures holistic care tailored to the unique needs of the patients.

While GLP-1 RAs show immense promise, the review calls for cautious optimism. Long-term data on the implications of these medications for fertility and pregnancy outcomes are still lacking. Healthcare providers are urged to remain attentive to emerging research to refine their approach and maximize benefits for patients.

This review reinforces the need to address the obesity epidemic within fertility care. By embracing innovative treatments like GLP-1 RAs and fostering a compassionate, informed approach, healthcare providers can improve outcomes for patients navigating the challenges of obesity and infertility.

Based on the review, the researchers promote the integration of GLP-1 receptor agonists as a primary treatment for obesity in preconception care by reproductive endocrinologists, highlighting these medications as “the most effective and least invasive option for achieving weight loss.

“Pre-pregnancy weight loss in individuals with obesity can potentially restore ovulation and enhance both maternal and fetal outcomes. However, the lack of long-term data necessitates close monitoring of ongoing and future research in this area,” the researchers concluded.

Reference:

Goldberg AS, Boots CE. Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists. Fertil Steril. 2024 Aug;122(2):211-218. doi: 10.1016/j.fertnstert.2024.05.154. Epub 2024 May 27. PMID: 38810863.

Powered by WPeMatico